Newly public biotech co. Coya Therapeutics hires new president, chief medical officer


Following its IPO in early 2023, Coya Therapeutics brought in a chief medical officer with over 20 years in the business.

Previous Allegheny Health Network to support Israeli health care startups following new partnership
Next REVIEW: Cincinnati Opera’s ‘Barber’ delights in a hilarious romp